The French Medicines Agency has decided to sanction 11 pharmaceutical companies that did not respect the minimum four-month stocks for drugs “of major therapeutic interest”, handing them a record fine amounting to €8 million. This is 16 times the amount of sanctions imposed in one year, suggesting that the agency is shifting its strategy to address shortages of medication in the country. FRANCE 24’s Julia Sieger tells us more.
Trending
- Best and worst hotel chains ranked by cost and customer score | Money News
- EV drivers could face new tax in Budget
- New ‘brain atlases’ may change fight against Alzheimer’s, MS – DW – 11/05/2025
- Tech giants warn Reeves of IPO ‘flight risk’ over budget | Money News
- ‘Vibe coding’ named word of the year by Collins Dictionary
- ‘Wetenschappers met belangen in afslankindustrie beïnvloeden obesitasdebat’
- Leeds maternity inquiry must include care culture, says father
- FIFA unveils new Peace Prize ahead of 2026 World Cup draw in Washington
